Tennessee HB 765: Controlled Substances - As introduced, permits a prescriber who is not a patient's obstetrical or gynecological provider to prescribe buprenorphine products to certain patients if the prescriber is a member of the same specialty practice group as the patient's obstetrical or gynecological provider. - Amends TCA Title 33; Title 53 and Title 63.

Status: Returned to the Clerk's Desk. (as of 2020-02-19)

State: Tennessee · Session: 111 · Bill: HB 765

Subjects: Controlled Substances

Sponsors: Love, Yarbro

View Tennessee HB 765 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.